{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:16:02Z","timestamp":1792016162833,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejim.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T01:19:24Z","timestamp":1515460764000},"page":"7-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":260,"special_numbering":"C","title":["The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report"],"prefix":"10.1016","volume":"49","author":[{"given":"Donald I.","family":"Abrams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2018.01.003_bb0005","series-title":"Marijuana and Medicine: Assessing the Science Base","year":"1999"},{"key":"10.1016\/j.ejim.2018.01.003_bb0010","series-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","author":"National Academies of Sciences, Engineering and Medicine","year":"2017"},{"issue":"1","key":"10.1016\/j.ejim.2018.01.003_bb0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of medical Cannabis users: patterns of use and perceived efficacy","volume":"1","author":"Sexton","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"issue":"24","key":"10.1016\/j.ejim.2018.01.003_bb0020","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejim.2018.01.003_bb0025","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jpain.2015.07.009","article-title":"Inhaled Cannabis for chronic neuropathic pain: a meta-analysis of individual patient data","volume":"16","author":"Andreae","year":"2015","journal-title":"J Pain"},{"issue":"5","key":"10.1016\/j.ejim.2018.01.003_bb0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/M17-0155","article-title":"The effects of Cannabis among adults with chronic pain and an overview of general harms: a systematic review","volume":"167","author":"Nugent","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ejim.2018.01.003_bb0035","article-title":"Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood","author":"Phillips","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2018.01.003_bb0040","article-title":"Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood","volume":"2","author":"Phillips","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"28","key":"10.1016\/j.ejim.2018.01.003_bb0045","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"35","author":"Hesketh","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejim.2018.01.003_bb0050","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1185\/030079907X167525","article-title":"Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting","volume":"23","author":"Meiri","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.ejim.2018.01.003_bb0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1517\/17460441.2011.560935","article-title":"A drug discovery case history of \u2018delta-9-tetrahydrocannabinol, cannabidiol\u2019","volume":"6","author":"Tanasescu","year":"2011","journal-title":"Expert Opin Drug Discovery"},{"issue":"17","key":"10.1016\/j.ejim.2018.01.003_bb0060","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the guideline development Subcommittee of the American Academy of Neurology","volume":"82","author":"Koppel","year":"2014","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ejim.2018.01.003_bb0065","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1007\/s00415-015-7878-1","article-title":"Sativex\u00ae and clinicalneurophysiological measures of spasticity in progressive multiple sclerosis","volume":"262","author":"Leocani","year":"2015","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.ejim.2018.01.003_bb0070","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tips.2016.12.004","article-title":"Cannabidiol claims and misconceptions","volume":"38","author":"Russo","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.ejim.2018.01.003_bb0075","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-139-4-200308190-00008","article-title":"Short-term effects of cannabinoids in patients with HIV-1 Infection. A randomized, placebo-controlled clinical trial","volume":"139","author":"Abrams","year":"2003","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ejim.2018.01.003_bb0080","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2018.01.003_bb0085","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.ejim.2018.01.003_bb0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.7326\/M17-0477","article-title":"Benefits and harms of plant-based Cannabis for posttraumatic stress disorder: a systematic review","volume":"167","author":"O'neil","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2018.01.003_bb0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/294264","article-title":"Treatment of Tourette syndrome with cannabinoids","volume":"27","author":"M\u00fcller-Vahl","year":"2013","journal-title":"Behav Neurol"},{"issue":"5","key":"10.1016\/j.ejim.2018.01.003_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/brainsci7050047","article-title":"Significant Tic reduction in an otherwise treatment-resistant patient with Gilles de la Tourette syndrome following treatment with Nabiximols","volume":"7","author":"Kanaan","year":"2017","journal-title":"Brain Sci"},{"issue":"1","key":"10.1016\/j.ejim.2018.01.003_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-013-1277-1","article-title":"Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas","volume":"116","author":"Rocha","year":"2014","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.ejim.2018.01.003_bb0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bjc.6603236","article-title":"A pilot clinical study of \u03949-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme","volume":"95","author":"Guzman","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejim.2018.01.003_bb0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/1535-7163.MCT-09-0407","article-title":"Cannabidiol enhances the inhibitory effects of \u03949-tetrahydrocannabinol on human glioblastoma cell proliferation and survival","volume":"9","author":"Marcu","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejim.2018.01.003_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00361","article-title":"Preclinical and clinical assessment of cannabinoids as anti-cancer agents","volume":"7","author":"Ladin","year":"2016","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.ejim.2018.01.003_bb0135","article-title":"Cannabinoids for epilepsy","author":"Gloss","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejim.2018.01.003_bb0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s13311-015-0375-5","article-title":"Cannabinoids and epilepsy","volume":"12","author":"Rosenberg","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.ejim.2018.01.003_bb0145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2018.01.003_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.seizure.2016.01.004","article-title":"CBD-enriched medical Cannabis for intractable pediatric epilepsy: the current Israeli experience","volume":"35","author":"Tzadok","year":"2016","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.ejim.2018.01.003_bb0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2982.2011.01874.x","article-title":"Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea","volume":"24","author":"Wong","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.ejim.2018.01.003_bb0160","first-page":"1","article-title":"Low-dose cannabidiol is safe but not effective in the treatment for Crohn's disease, a randomized controlled trial","author":"Naftali","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.ejim.2018.01.003_bb0165","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jpain.2016.03.002","article-title":"Medical Cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain","volume":"17","author":"Boehnke","year":"2016","journal-title":"J Pain"},{"issue":"9","key":"10.1016\/j.ejim.2018.01.003_bb0170","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings","volume":"38","author":"Morgan","year":"2013","journal-title":"Addict Behav"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T16:52:23Z","timestamp":1535129543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620518300037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":32,"alternative-id":["S0953620518300037"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2018.01.003","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}